The phosphorylation and dephosphorylation of proteins on serine and threonine residues is an essential means of regulating a broad range of cellular functions in eukaryotes, including cell division, homeostasis and apoptosis. A group of proteins that are intimately involved in this process are the serine/threonine (Ser/Thr) protein kinases. DCAMKL3 (doublecortin-like and CAM kinase-like 3), also known as DCLK3 or DCDC3C, is a 648 amino acid protein that localizes to both the nucleus and the cytoplasm and contains one protein kinase domain. One of several members of the Ser/Thr protein kinase family, DCAMKL3 functions to catalyze the ATP-dependent attachment of a phospho residue to target proteins, an event that may play a role in various cellular processes.
DCAMKL3 Polyclonal Antibody detects endogenous levels of DCAMKL3 protein.
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB: 1:500-1:2000, IHC-p: 1:100-1:300, ELISA: 1:5000. Not yet tested in other applications.
DCAMKL3 Polyclonal Antibody product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.
Find more details at http://www.abbkine.com/product/dcamkl3-polyclonal-antibody-abp51152.
bio-equip.cn
Abbkine Scientific Co., Ltd. was founded by a number of scientists and marketing experts in the field of life science in California in 2012. With growing demands from Asia Pacific, it move its headquarters to China. Combining cutting edge technology from United States with China's manufacturing engineering and cost advantages, we aim to provide innovative, high quality assay kits, recombinant proteins, antibodies and other research tools to accelerate life science fundamental research, drug discovery, etc.